Quibim, a health tech company designing AI tools to unlock clinical imaging data, secured $50m in an oversubscribed series A funding round, announced today. The round will finance high-performance computing for training AI and support building commercial and business development teams for product launch in the US, Ángel Alberich-Bayarri, Quibim CEO, told Medtech Insight.
Quibim $50m Series A To Fund High-Performance Computing And US Expansion
Quibim announces $50m in an oversubscribed series A funding round. Quibim CEO Ángel Alberich-Bayarri discusses his plans for the new financing and the company’s competitive edge in training AI with multimodal data.
